Mergers & Acquisitions - Licensing, Forest Laboratories

Filter

Popular Filters

Forest acquires rights to Nabriva antibacterial and option to buy firm

04-06-2012

US drugmaker Forest Laboratories (NYSE: FRX) says it has entered into an agreement with Austrian biotech…

Antibiotics and Infectious diseasesBC-3781BiotechnologyForest LaboratoriesLicensingMergers & AcquisitionsNabriva TherapeuticsPharmaceutical

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top